SAShakir Mahmood Alwan

Shakir Mahmood Alwan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shakir Mahmood Alwan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In Silico Molecular Modelling and Dynamic Simulations, ADME Parameters Predictions of new Naproxen Analogues Containing 1,3,4-Oxadiazole as Anti-inflammatory Agents

    by Farooq Algaragoolee, Ayad Kareem, Shakir Mahmood Alwan

    The serious challenges associated with the non-steroidal anti-inflammatory drugs (NSAIDs), especially their unfavorable impacts on the gastrointestinal tract (GIT)and kidneys arise from restraining cyclooxygenase (COX) enzymes. To address this issue and manage the side effects, several investigations were employed by modifying and adjusting the free carboxyl group of NSAIDs to upgrade their safety profile, while, keeping up their anti-inflammatory adequacy. An approach of suggesting new analogues of NSAIDS focusing on COX-2 enzyme devoid of side effects on stomach or kidneys is highly recommended. In this respect, the design of new analogues of naproxen is investigated by insertion of the carboxylic group into a 1,3,4-oxadiazole ring structure. This chemical modification points to hold anti-inflammatory impacts, whereas decreasing the hazard of stomach irritation and ulceration. These analogues were evaluated by means of computational methods, such as molecular docking, virtual screening, ADME (absorption, distribution, metabolism, and excretion) and molecular dynamics. The proposed compounds exhibited encouraging binding affinities to the COX-2 receptor, as demonstrated by molecular docking and molecular dynamic simulations. This may suggest that these compounds have the potential to be effective anti-inflammatory agents. Moreover, in silico ADME appraisals showed favorable pharmacokinetic profiles for the compounds that may suggest safer choices to known NSAIDs. Virtual evaluations of the new naproxen analogues have indicated their anti-inflammatory activity. These evaluations and the promising binding affinities and favorable pharmacokinetic profiles bolster the basis for advance preclinical and clinical ponders to approve the high potential of these compounds. Molecular dynamics simulations provide experiences into the energetic stability of the protein-ligand complex, with RMSD and RMSF investigations demonstrate steady interactions during time. This chemical modification offers a promising approach for the development of safer anti-inflammatory analogues of naproxen.


  • Open Access

    Pharmacophore-guided machine learning and molecular simulations of pyrazole-imine ligands targeting estrogen receptor alpha

    by Hayder H. Kadhim, Ayad M.R. Raauf, Shakir Mahmood A Lwan

    Estrogen receptor alpha (ERα) plays a crucial role in breast cancer progression, making it a key target for selective estrogen receptor modulators (SERMs). While Raloxifene has demonstrated therapeutic efficacy, resistance and limited bioactivity in some cases necessitate the development of novel ERα inhibitors with improved pharmacological profiles. A computational drug discovery approach integrating molecular docking, molecular dynamics (MD) simulations, and quantitative structure-activity relationship (QSAR) modeling was employed to design and evaluate new ERα inhibitors. Molecular docking was performed using Glide (XP mode) to predict ligand binding affinity and interaction patterns, while MD simulations over 100 ns assessed the stability and conformational dynamics of the protein-ligand complexes. A QSAR model was developed using a dataset of 1,231 compounds from ChEMBL, incorporating XGBoost regression with optimized hyperparameters for robust predictive performance. Compounds 3b, 3a, and 4a showed notable binding affinities (−9.319, −9.121, and −8.867 kcal/mol, respectively) that are comparable to Raloxifene (−9.791 kcal/mol), suggesting their potential as effective ERα ligands primarily through pi-pi stacking with PHE-404 and hydrogen bonding with Glu 353. MD simulations demonstrated that 3a, 4a, and 4b maintained stable receptor interactions (RMSD < 2.0 Å), while 3e and 4e exhibited higher fluctuations, indicating weaker engagement. The QSAR model achieved high predictive accuracy (RMSE < 0.6, R² > 0.8), identifying NO₂ (3d), OMe (3c), and Cl (3b) substitutions as key structural features enhancing receptor binding. This study identifies 3b, 3d, and 4b as promising lead compounds with strong binding affinity, stability, and predicted estrogen receptor activity. These findings provide a basis for further experimental validation and structural refinement to develop next-generation SERMs for ERα-positive breast cancer therapy.

  • Open Access

    In Silico Profiling of Binding Affinities of Hybrid Molecules of Oseltamivir carboxamides cross-linked with Hydroxamic acid as possible Anti-influenza agents

    by Sumia Samer Tayah, Shakir Mahmood Alwan, Kenza Mansoor

    الإنفلونزا هي مرض تنفسي معدي يسببه فيروس الإنفلونزا، وهو قضية صحية عامة عالمية مستمرة وهامة. يظهر هذا العدوى تصاعداً متكرراً خلال فصول معينة وفي بعض الأحيان تفشيات واسعة المدى. تمت الموافقة على عدد من الأدوية واللقاحات وتوصي بها لعلاج هذه العدوى. أوزيلتاميفير هو دواء معتمد من قبل إدارة الغذاء والدواء الأمريكية لعلاج الإنفلونزا، حيث يعمل عن طريق تثبيط إنزيم نيوراميداز الإنفلونزا، ويُستخدم في الإدارة العلاجية والوقائية لأنواع الإنفلونزا A و B، وبهذه الطريقة يمنع تكوين الفيروس وإطلاقه ويحجب انتشار الفيروس ويخفف من شدة ومدة الإصابة بالإنفلونزا. يُسكب أوزيلتاميفير كبرو-دواء في شكل استر الإيثيل، وفي الجسم، تحوله الإستيرازات الكبدية إلى أوزيلتاميفير الكاربوكسيلات الفعّال. يُعتبر نهج تخليق كاربوكساميدات أوزيلتاميفير مع بعض الأحماض الأمينية المحددة (السلسلة الأولى) وتكامل أوزيلتاميفير مع حمض الأمين وحمض الهيدروكساميك كجزيئات مختلطة (السلسلة الثانية)، ويُفترض أن يعززوا الفعالية والاختراق إلى أعضاء متنوعة، بما في ذلك أنسجة الرئة، ويديرون مقاومة أوزيلتاميفير. تمت خضوع هاتين السلسلتين من...


  • Open Access

    Molecular docking, synthesis and preliminary evaluation of hybrid molecules of benzothiazole cross-linked with hydroxamic acid by certain linkers as HDAC inhibitors

    by Yazen Abdul-Hameed, Shakir Mahmood Alwan, Ashour Humood Dawood

    Background Molecular hybridization in drug design is proved to be very successful approach to provide new chemical entities with potential activities and desirable physicochemical properties. Histone deacetylases (HDACs) are involved in controlling the behavior and acetylation of histone and non-histone proteins and their inhibition causes block of cell growth, differentiation, changes in gene expression, and death. Consequently, HDAC inhibitors may lead to anticytotoxic activity. An approach of synthesizing hybrid molecules of benzothiazole cross-linked with hydroxamic acid via an amino acid or aminoalkanoic acid was considered. This approach is expected to optimize the anticytotoxic activity of the proposed compounds. Methods Hybrid molecules of benzothiazole cross-linked with hydroxamic acid (2A-E) were synthesized and their chemical structures were confirmed by spectral analyses (FT-IR, 1H-NMR and 13C-NMR). These were subjected to molecular docking on HDAC8 (PDB ID: 1T69). Computational methods were employed using the SwissADME server to predict the ADME parameters and other physicochemical properties. The cytotoxicity evaluation was performed using MTT colorimetric assay. Results Hybrids (2A-E) recorded lower ΔG (-6.322 to - 9.46) than Vorinostat (SAHA, -5.375). ΔG is an affinity scoring function (kcal/mol) and is employed to rank the candidate poses as the sum of the electrostatic and Van der Waals energies. Benzothiazole cross-linked with hydroxamic acid by a p-aminobenzoic acid (2E) has recorded the lowest docking score of -9.460 and this may refer to the possibility of high inhibitory activity. The hybrids showed no violation from Lipinski’s rule and complied with parameters with low possible passive oral absorption and no penetration into BBB. Hybrid molecules of benzothiazole recorded very interesting results, particularly, 2D and 2E which showed significant and remarkable activity. Conclusions Hybrid molecules of benzothiazole cross-linked with hydroxamic acid recorded very interesting results, particularly, compounds 2D and 2E which showed significant and remarkable activity on lung cancer cell line type A549.

  • Open Access

    Design, molecular docking, synthesis and in vitro evaluation of anti-influenza activity of oseltamivir carboxamides and their hybrid molecules with hydroxamic acid

    by Sumia Samer Tayah, Shakir Mahmood Alwan

    Background The influenza virus is a highly contagious respiratory disease that causes seasonal outbreaks and occasionally, unpredictable pandemics with high morbidity and mortality rates. This problem is exacerbated by the lack of drugs with potential antiviral activity against all types of influenza strains, including resistant strains. Therefore, there is an urgent need to develop novel antiviral agents. Methods The synthesis of new oseltamivir carboxamides with amino acids and the subsequent synthesis of hybrid molecules with hydroxamic acid were considered. Two series are presented as series one; oseltamivir carboxamides with L-serine, L-isoleucine, L-phenylalanine, L-tyrosine and series two included hydroxamates of series one. This approach may provide promising candidates with potential anti-influenza activity. The in vitro cytotoxic activity against Madin-Darby Canine Kidney (MDCK), type (NBL-2) - CCL-34 cells using the MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to determine the half maximal inhibitory concentrations (IC50) of the investigated compounds. The percent inhibition of neuraminidase was plotted against concentrations and the IC50 values were calculated by non-linear logistic curve fitting. Results The compounds were subjected to molecular docking using the GOLD suite (version 5.7.1) to predict the binding affinities for neuraminidase (3CL0). The docking scores are presented as PLP fitness and are comparable to those of oseltamivir. Oseltamivir-Phenylalanine recorded the highest docking score (72.23 kcal/mol), while, oseltamivir acid was recorded (56.24 kcal/mol). The ADMET parameters were generated using the Swiss ADME server to predict successful candidates with reasonable oral absorption and safety margins. All compounds are safer than oseltamivir and their IC50 values for neuraminidase inhibition were variable. The hybrids showed a lower percentage of viable cells. Oseltamivir-phenylalanine had the highest inhibitory activity against neuraminidase (3.03 μM), when compared with oseltamivir (67.22 μM). Conclusion Oseltamivir-phenylalanine showed remarkable and very significant activity, and the hybrid molecules were surprisingly less effective on neuraminidase than oseltamivir carboxamides.

  • Open Access

    In Silico Molecular Docking, Synthesis and Preliminary Evaluation of Antibacterial Activity of Levofloxacin Carboxamides with Certain Amino Acids

    by Sarah Abdul-Razzaq Makki, Shakir M Alwan, Mayada H. Al-Qaissy

    Levofloxacin carboxamides with certain amino acids were prepared through an amide linkage to the amino acid (glycine, histidine, or serine). These carboxamides were subjected to an in silico molecular docking evaluation on DNA gyrase to predict their antibacterial activity using the GOLD suite. The binding affinities were very significant and encouraged the synthesis of the suggested carboxamides for intensive evaluation. These carboxamides were also subjected to Swiss ADME software to predict their ADME parameters. Levofloxacin carboxamides were prepared in high yield, and their chemical structures were confirmed by spectral analysis, such as 1H-NMR, 13C-NMR and FT-IR spectroscopy. Antibacterial activities were evaluated for the new carboxamides against two G-ve (Klebsiella and P. aeruginosa) and one G+ve (Streptococcus pneumonia) bacteria. When compared to levofloxacin, all of the synthesized carboxamides 1-3 demonstrated good activity against three types of bacteria. These carboxamides showed significant antibacterial activities against S. pneumoniae and lower activities against Klebsiella.


  • Open Access

    In Silico Molecular Docking Study for Prediction of Binding Affinities to Penicillin Binding Proteins and β-Lactamases of Amino Acids-Cephalexin conjugates

    by Shakir Mahmood Alwan, Jaafar S. Shia

    Cephalexin is a first generation cephalosporin with high antibacterial activity against a number of microbes. Cephalexin is highly sensitive and could be hydrolyzed by almost all of β-lactamases. An in silico prediction and evaluation study is performed to find a possibility of bringing new life to cephalexin, and other cephalosporins that are susceptible to hydrolysis by lactamases. This approach includes an introduction of an amino acid moiety into cephalexin through an amide bond with its primary amine group. This amino acid moiety is expected to provide steric hindrance and protecting the β-lactam ring from being hydrolyzed. In silico study included measurement of binding affinity to penicillin binding proteins (PBPs) and D-alanyl-D-alanine carboxypeptidases and to β-lactamases. Drug likeness and Molinspiration calculations were recorded to find a reliable correlation with better activity and stability against β-lactamases. The newly suggested conjugates that recorded the best score of binding affinity on PBPs are L-Phe-Cephalexin, L-Arg-Cephalexin, L-Tyr-Cephalexin and L-Thr-Cephalexin. Two of these conjugates, namely, L-Arg-Cephalexin and L-Tyr-Cephalexin recorded high binding affinity scores on D-alanyl-D-alanine carboxypeptidases. Moreover, the predicted stability of L-Arg-Cephalexin and L-Tyr-Cephalexin conjugates against β-lactamases was recorded. Drug-Likeness parameters have shown that L-Cys-Cephalexin, L-Lys-Cephalexin and L-Arg-Cephalexin conjugates were the best compounds recording the highest binding affinity. In conclusion, the amino acid-linked cephalexin conjugates were found to possess high binding affinity to PBPs, D-alanyl-D-alanine carboxypeptidases and β-lactamases, which may encourage the synthesis and intensive evaluation.